Pacifico Biolabs Raises €7 Million in Series A Funding
Pacifico Biolabs, a biotech company based in Leipzig, Germany, has successfully closed a €7 million Series A funding round. The round was led by Stray Dog Capital, with participation from other investors including TGFS, Sprout, About Ventures, Simon Capital, FoodLabs, and a Regional Brewery Partner.
Focus on Mycelium Fermentation
Pacifico Biolabs specializes in utilizing mycelium fermentation to produce sustainable food products. The company aims to leverage Europe's disused brewery tanks to scale its production capabilities. This innovative approach not only promotes sustainability but also taps into existing infrastructure to reduce costs and environmental impact.
Strategic Use of Funds
The newly acquired funds will primarily be used to expand the company's production capacity across Europe. By repurposing brewery tanks for mycelium fermentation, Pacifico Biolabs plans to enhance its operational efficiency and meet the growing demand for sustainable food alternatives.
Investors and Industry Impact
Stray Dog Capital, known for its investments in sustainable food technologies, led the funding round. The participation of other investors such as TGFS, Sprout, About Ventures, Simon Capital, FoodLabs, and a Regional Brewery Partner highlights a growing interest in innovative food tech solutions. This funding round positions Pacifico Biolabs to further cement its role in the sustainable food industry.
Looking Ahead
With the new capital, Pacifico Biolabs is set to scale its operations and bring its sustainable food products to a broader market. The company’s use of existing brewery infrastructure presents a unique opportunity to expand efficiently while maintaining a focus on sustainability.
As the demand for eco-friendly food options continues to rise, Pacifico Biolabs is well-positioned to capitalize on this trend, offering an alternative that aligns with both consumer preferences and environmental needs.